We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance has been published about thalidomide, lenalidomide, and pomalidomide and the use of remote consultations and home pregnancy testing for patients taking them during COVID-19.
Atomoxetine is associated with treatment-emergent psychotic or manic symptoms in children and adolescents - consider stopping this if symptoms occur.
Healthcare professionals should consider measuring magnesium levels before starting PPI treatment and repeat measurements periodically during prolonged treatment.
Action taken as suppliers increase stocks of hormone replacement therapy (HRT) products.
First published during the 2019 to 2022 Johnson Conservative government
The Medicines and Healthcare products Regulatory Agency (MHRA) announced the UK’s biggest seizure of smart drugs, also known as cognitive enhancers or nootropics.
Two so-called ‘legal’ highs linked to deaths across Europe are set to be banned, the government announced today.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Ban on five substances will come into force at 00:01 on Friday 10 April for up to 12 months.
Government response to the ACMD's advice on the synthetic opioid AH-7921, a number of LSD related compounds and tryptamine.
Home Office circular 039 / 2003 CONTROLLED DRUGS Broad subject: Crime and Disorder Issue date: Wed Jun 25 00:00:00 BST 2003 From: CRIME…
Two new so-called “legal highs” have been banned by the Government.
First published during the 2015 to 2016 Cameron Conservative government
New guidance states NHS and local authorities are to provide support for people addicted to prescription or over-the-counter medicines.
A number of so-called ‘legal highs’ will become illegal class b drugs, the Home Office announced today.
New maximum daily dose restrictions (including in elderly patients), contraindications, and warnings.
Coadministration of a corticosteroid with an HIV-treatment-boosting agent may increase the risk of adrenal suppression due to a pharmacokinetic interaction.
Upper Tribunal Administrative Appeals Chamber decision of Judge Rowland on 29 May 2020.
A stimulant used predominately by members of the UK’s Somali, Yemeni and Ethiopian communities is to be reviewed.
A lethal psychedelic drug should be controlled as a Class A substance, according to the Advisory Council on the Misuse of Drugs (ACMD).
Crime prevention minister writes to the Advisory Council on the Misuse of Drugs to accept their recommendation to control these 2 drugs as Class A drugs.
Sarah Newton reponds to the Advisory Council on the Misuse of Drugs about its further advice on methylphenidate-based drugs and phytocannabinoids.
First published during the 2016 to 2019 May Conservative government
More than 60 officials from various branches of the Guatemalan Government participated in a one-week training session aimed at increasing the capabilities of the country in the management of psychoactive substances and chemical precursors - raw materials for the increasingly...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).